RxSight, Inc. (RXST) — Analyst outlook / Analyst consensus target is. Based on 12 analyst ratings, the consensus is bullish — 3 Buy, 7 Hold, 2 Sell.
The consensus price target is $11.00 (low: $10.00, high: $13.00), representing an upside of 51.3% from the current price $7.27.
Analysts estimate Earnings Per Share (EPS) of $-0.72 and revenue of $0.14B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-0.71 vs est $-0.72 (beat +1.8%). 2025: actual $-0.95 vs est $-1.05 (beat +9.8%). Analyst accuracy: 94%.
RXST Stock — 12-Month Price Forecast
$11.00
▲ +51.31% Upside
Average Price Target
Based on 12 Wall Street analysts offering 12-month price targets for RxSight, Inc., the average price target is $11.00, with a high forecast of $13.00, and a low forecast of $10.00.
The average price target represents a +51.31% change from the last price of $7.27.
Highest Price Target
$13.00
Average Price Target
$11.00
Lowest Price Target
$10.00
RXST Analyst Ratings
Hold
Based on 12 analysts giving stock ratings to RxSight, Inc. in the past 3 months
EPS Estimates — RXST
94%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$0.71
vs Est –$0.72
▲ 1.8% off
2025
Actual –$0.95
vs Est –$1.05
▲ 10.9% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — RXST
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.140B
vs Est $0.140B
▼ 0.1% off
2025
Actual $0.134B
vs Est $0.132B
▲ 2.1% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
